Cargando…

Miniaturized percutaneous nephrolithotomy: Is smaller really better?

Detalles Bibliográficos
Autor principal:	Sharma, Gopal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555560/ https://www.ncbi.nlm.nih.gov/pubmed/34759532 http://dx.doi.org/10.4103/iju.iju_175_21

Ejemplares similares

Totally tubeless percutaneous nephrolithotomy: Is it safe?
por: Nirmal, T. J., et al.
Publicado: (2009)

Application of a fluoroscopy protocol in percutaneous nephrolithotomy to decrease radiation exposure: A feasible option
por: Choudhary, Gautam Ram
Publicado: (2014)

Malignant ureteral obstruction: Whether decompression really improves patient outcomes and quality of life?
por: Muruganandham, K., et al.
Publicado: (2008)

Simplified PADUA REnal nephrometry system: A refitted PADUA score
por: Sharma, Gopal
Publicado: (2020)

Which one is better, Wallace or Bricker?
por: Khurana, Naval, et al.
Publicado: (2007)

Urethral reconstructive surgery: Which catheters are better?
por: Suryavanshi, Manav, et al.
Publicado: (2008)

Is there a better indicator for predicting the outcome of trial without catheter?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

The ARAMIS trial: Why Darolutamide is better than apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer
por: Tripathy, Sambit
Publicado: (2021)

A game changing LATITUDE: Role of abiraterone plus prednisolone in metastatic hormone-sensitive prostate cancer
por: Sharma, Aditya Prakash
Publicado: (2017)

Pharmacological prophylaxis for venous thromboembolism: Is it time to change the gold standard?
por: Kumaraswamy, Santosh
Publicado: (2021)

Nectin-4 inhibitors: An ace up our sleeve against advanced urothelial carcinoma
por: Kumaraswamy, Santosh
Publicado: (2021)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?
por: Kumar, Naveen
Publicado: (2021)

VISION trial: (177)Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer
por: Rohith, Gorrepati
Publicado: (2021)

Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057)
por: Kumar, Bhuwan
Publicado: (2021)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
por: Kumaraswamy, Santosh
Publicado: (2021)

The SMART trial; does it make us wiser in choosing between sirolimus in preference to cyclosporine – A postrenal transplant?
por: Mishra, Ankit
Publicado: (2021)

Role of atezolizumab therapy combined with platinum-based chemotherapy in untreated metastatic urothelial carcinoma – The new landscapes (IMvigor130 trial)
por: Misra, Ankit
Publicado: (2021)

Can early salvage radiotherapy replace adjuvant radiotherapy as the new standard of care for high-risk postradical prostatectomy patients?
por: Pandey, Abhishek
Publicado: (2021)

HERO trial: A rescue from injectable androgen deprivation therapy
por: Ranjan, Satish Kumar
Publicado: (2021)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Intravesical real-time imaging and staging of bladder cancer: Use of optical coherence tomography
por: Sengottayan, Vengatesh K., et al.
Publicado: (2008)

Survival following primary androgen deprivation therapy among men with localized prostate cancer
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Is lap nephrectomy superior to open? A randomized trial
por: Kumar, Anup, et al.
Publicado: (2008)

Risk factors for persistent stress urinary incontinence after mid-urethral procedures
por: Chawla, Arun, et al.
Publicado: (2008)

Botulinum toxin in high-risk BPH patients in retention
por: Reddy, Sreedhar, et al.
Publicado: (2008)

Combined dorsal plus ventral double buccal mucosa graft in bulbar urethral reconstruction
por: Chawla, Arun, et al.
Publicado: (2008)

Does tamsulosin facilitate expulsion of distal ureteric calculus following lithotripsy?
por: Gupta, Gaurav, et al.
Publicado: (2008)

Partial nephrectomy for small renal tumors may prevent chronic kidney disease
por: Kumar, Rajeev
Publicado: (2008)

Ureteroilleal anastomosis in orthotopic ileal neobladders: Does technique matter?
por: Gupta, Parag, et al.
Publicado: (2008)

Can tomato juice be used for prophylaxis in recurrent stone formers?
por: Agrawal, Madhu S., et al.
Publicado: (2009)

Antibiotic prophylaxis in vesicoureteral reflux: A paradigm shift
por: Banerji, J. S., et al.
Publicado: (2009)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
por: Vasudeva, Pawan, et al.
Publicado: (2008)

What is the treatment of choice for bulbar urethral strictures which are not an indication for visual internal urethrotomy?
por: Dubey, Deepak, et al.
Publicado: (2008)

Does early orchidopexy reduce risk of testicular cancer?
por: Banerji, John S., et al.
Publicado: (2008)

Follow-up after pyeloplasty: How long?
por: Nirmal, T. J., et al.
Publicado: (2008)

Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial
por: Dubey, Deepak, et al.
Publicado: (2008)

Optimizing bowel recovery after laparoscopic donor nephrectomy
por: Prakash, Gagan, et al.
Publicado: (2008)

Can micturating cystourethrograms be avoided in follow-up of antenatally diagnosed hydronephrosis?
por: Chawla, Arun, et al.
Publicado: (2008)

Nitrous oxide during anesthesia for laparoscopic donor nephrectomy: Does it matter?
por: Singh, Pratipal, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_iqe74cstaciup1jdkee74j29en